G1 Therapeutics

-$0.06 (-0.34%) As of 5:32 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GTHX and other ETFs, options, and stocks.

About GTHX

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib.

CEO
Jack Bailey
Employees
122
Headquarters
Research Triangle Park, North Carolina
Founded
2008

GTHX Key Statistics

Market Cap
903.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.03M
High Today
$18.05
Low Today
$17.44
Open Price
$17.58
Volume
218.16K
52 Week High
$37.07
52 Week Low
$10.81

GTHX Earnings

-$1.07
-$0.71
-$0.36
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure